Cyclosporine A micellar nasal spray characterization and antiviral action against SARS-CoV-2

Nasal spray innovation with micellar delivery of Cyclosporine A holds promise in combating SARS-CoV-2 infections

Intranasal Drug Delivery: Unravelling the Nanoparticle Formulation Puzzle

Navigate the complexities of formulating nanoparticles for intranasal drug delivery with expert insights

Novel Aerosol Apparatus for Inhaler Testing in OINDPs

Explore a case study for UniDose in the development of a novel aerosol collection apparatus for dissolution testing of orally inhaled drugs.

Nanopharm Value Creation with OINDP Innovation

Discover Nanopharm’s pre-clinical OINDP solutions using SmartTrack for cutting-edge MDI development, transforming respiratory drug research.

Nanopharm Case Study on Computational Modelling

Accelerate injectable drug reformulation for nasal delivery using modelling. Uncover clinical benefits and innovation in nasal pharmaceuticals.

Nanopharm Newsletter May 2023

Explore Nanopharm’s SmartTrack™ for OINDPs and uncover the role of PBPK in nasal drug delivery.

Why it is time to ‘Think Different’ about nasal delivery of biologics.

Nanopharm discusses the challenges and benefits of delivering biologics via the nasal route.

Nasal Drug Development, Trends and Challenges with Nasal Formulations

Nanopharm explores the current trends and technical challenges in nasal drug product development, focusing on formulation.

Nanopharm’s Innovations in Nasal Drug Delivery of Biologics

Discover Nanopharm’s pioneering work in nasal drug delivery of biologics. Learn how their research is shaping drug development against SARS-CoV-2.

Conversations with Dr Julie Suman, on Nasal Drug Delivery: Current trends, technical challenges and opportunities for therapeutic innovation

Aptar Pharma present data on the challenges and opportunities for Nasal drug delivery.